Methotrexate is prescribed to at least 500,000 patients with rheumatoid arthritis (RA) worldwide; the best route of administration, however, is not clear. This multicenter, phase IV, randomized, ...

This study was an international randomized trial comparing six courses of methotrexate 1 g/m 2 over 24 hours and IT chemotherapy (MTX1 arm) with six courses of methotrexate 3 g/m 2 over 3 hours ...

Two other potentially important questions not addressed in this analysis are the effect of the cell dose 5 and the effect of the administration of myeloid growth factors early after transplantation. 6 ...

Please provide your email address to receive an email when new articles are posted on . Subcutaneous methotrexate is safe in clinical practice, and is continued longer and better tolerated than other ...

Surrey, UK - A review on the use of folate as a supplement to methotrexate therapy in rheumatoid arthritis (RA) has prompted at least 1 UK doctor to change his prescribing habits. In their review, ...

Methotrexate is a primary disease-modifying anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA) by reducing inflammation and suppressing the immune system. The American College of ...

Methotrexate falls into the category of disease-modifying antirheumatic drugs, or DMARDs. These drugs do more than deal with symptoms; they actually slow down progression of the disease. About 60 ...

Methotrexate injection, a treatment for certain autoimmune diseases and cancers, can lead to various side effects. These range from common, mild reactions such as headache and nausea to serious, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “Currently, a gap exists in patient-centric studies that ...

Methotrexate injection device approved The FDA has approved Otrexup for adults with active, severe rheumatoid arthritis or psoriasis who haven't responded first line therapy and children with active ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks, the randomized PREDMETH trial showed. Mean change from baseline in the ...